Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 105, Issue 1
Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Clinical science
Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation
Online download statistics by month:
Online download statistics by month: March 2020 to May 2021
Abstract
Full
Pdf
Mar 2020
1941
865
843
Apr 2020
1705
1121
1095
May 2020
138
14
6
Jun 2020
147
9
2
Jul 2020
147
8
2
Aug 2020
134
5
2
Sep 2020
175
8
1
Oct 2020
134
9
1
Nov 2020
179
4
3
Dec 2020
674
24
20
Jan 2021
382
33
28
Feb 2021
83
16
13
Mar 2021
133
12
9
Apr 2021
255
14
11
May 2021
54
10
4
Total
6281
2152
2040
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF